ClinicalTrials.gg
Sign In

Neoplasms by Histologic Type clinical trials

The registry lists 133 studies for Neoplasms by Histologic Type across more than 10 countries. 37 are recruiting or about to start. 3 of them are mainly about Neoplasms by Histologic Type (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 238 narrower conditions too, such as Multiple Myeloma: 45,215 studies, 10,652 open.

Get an email when these change. Save the Neoplasms by Histologic Type studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
40
Recruiting
30
Terminated
26
Status unknown
14
Active, not recruiting
12
Not yet recruiting
5

Phase

Phase 2
60
Phase 1
55
Phase 3
20
Phase 4
2

Where

United States
70
United Kingdom
22
France
21
China
20
Italy
19
Germany
19

Who runs them

Cancer Research UK (7) · Blueprint Medicines Corporation (4) · Boston Scientific Corporation (3) · Royal Marsden NHS Foundation Trust (3) · Ariad Pharmaceuticals (3) · National Cancer Institute (NCI) (3) · Pfizer (3) · Sumitomo Pharma America, Inc. (2)

What is being tested here

Drugs under test in Neoplasms by Histologic Type studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dabrafenib222
Trametinib222
Alectinib222
Atezolizumab222
Entrectinib222
Vemurafenib222
Cobimetinib222
Capmatinib222
Olvimulogene nanivacirepvec102
Gemcitabine102

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 5 open · Immune checkpoint inhibitors 4 open · Antimetabolites 2 open · Angiogenesis inhibitors 4 · Alkylating agents 4

Coming up

8phase 3 studies under way
13studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 30 Neoplasms by Histologic Type studies recruiting now, 20 (67%) set no upper age limit and 5 (17%) stop at 75 or younger. 7 (23%) take children under 18. 1 (3%) are for women only and 1 (3%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 30
AgeWomenMen
106 (20%)6 (20%)
1827 (90%)27 (90%)
3027 (90%)27 (90%)
4027 (90%)27 (90%)
5028 (93%)28 (93%)
6528 (93%)28 (93%)
7527 (90%)27 (90%)
8524 (80%)24 (80%)

Across all 133 studies, recruiting or not: 14% stop at 75 or younger and 6% at 65; 13% take children; 8% are for women only and 1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Studies

Recruiting first, then most recently updated. Showing 50 of 133. Browse all 133 → or search them.